- Macrophage Inflammatory Protein $1{alpha}$가 T세포성장 및 CD4, CD8 발현에 미치는 영향
- ㆍ 저자명
- 최종선,김오환,Choi. Jong-Sun,Kim. Oh-Whan
- ㆍ 간행물명
- 대한악안면성형재건외과학회지
- ㆍ 권/호정보
- 1996년|18권 1호|pp.153-163 (11 pages)
- ㆍ 발행정보
- 대한악안면성형재건외과학회
- ㆍ 파일정보
- 정기간행물| PDF텍스트
- ㆍ 주제분야
- 기타
Macrophage inflammatory protein $(MIP)-1{alpha}$ is a cytokine which produces wide range of bioactivities such as proinflammatory, immunomodulatory, and hematopoietic modulatory actions. To determine whether $MIP-1{alpha}$ acts as a negative regulator on the functions of lymphocyte, $[^3H]$-thymidine incorporation test and flow cytometric analysis were performed by using human tonsil T cell, human peripheral blood T cell, and murine cytolytic T lymphocyte (CTL) line CTLL-2, The results were as follow. 1. When human tonsil T lymphocytes were stimulated with anti-CD3 monoclonal antibody (mAb), rate of T cell proliferation was about four times increased. 200ng/ml of $MIP-1{alpha}$ inhibited anti-CD3 mAb-mediated T cell growth as much as 60% (P<0.05). 2. The suppression of human peripheral T cell proliferation produced by $MIP-1{alpha}$ was dramatic, but variable among T cells derived from different individuals $(40%{sim}90%)$. 3. $MIP-1{alpha}$inhibited the proliferation of murine CTL line CTLL-2 as much as 75%(P<0.001). 4. When the $MIP-1{alpha}$ was added to human peripheral T cell, cell proporation of $CD4^+$ helper T cell and $CD8^+$ CTL were not noticeably affected. The expression level of CD4, not of Cd8, however, was down regulated by $MIP-1{alpha}$ treatment $(27%{sim}82%)$.